Evidence map›Paper›PMID 30631079›Full record

ArticleNature communications2019

GORAB scaffolds COPI at the trans-Golgi for efficient enzyme recycling and correct protein glycosylation.

Tomasz M Witkos, Wing Lee Chan, Merja Joensuu, Manuel Rhiel, Ed Pallister, Jane Thomas-Oates, A Paul Mould, Alex A Mironov, Christophe Biot, Yann Guerardel and 7 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 55 citations in OpenAlex.

  1. Review
  2. Review
  3. Molecular genetics and metabolism reports · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Role of theFrontiers in cell and developmental biology · 2022
    Review
  18. Article
  19. Article
  20. The role of the Golgi apparatus in disease (Review).International journal of molecular medicine · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 5 countries.

Tomasz M WitkosSchool of Biology, Faculty of Biology, Medicine and Health, University of Manchester, The Michael Smith Building, Oxford Road, Manchester, M13 9PT, UK.
Wing Lee ChanBerlin-Brandenburg Centre for Regenerative Therapies (BCRT), Institut fuer Medizinische Genetik und Humangenetik, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, 13353, Germany.
Merja JoensuuCell and Molecular Biology Program, Institute of Biotechnology, University of Helsinki, Helsinki, 00014, Finland.
Manuel RhielHeidelberg University Biochemistry Center, Heidelberg University, Heidelberg, 69120, Germany.
Ed PallisterDepartment of Chemistry, University of York, York, YO10 5DG, UK.
Jane Thomas-OatesDepartment of Chemistry, University of York, York, YO10 5DG, UK.ORCID http://orcid.org/0000-0001-8105-9423
A Paul MouldSchool of Biology, Faculty of Biology, Medicine and Health, University of Manchester, The Michael Smith Building, Oxford Road, Manchester, M13 9PT, UK.
Alex A MironovSchool of Biology, Faculty of Biology, Medicine and Health, University of Manchester, The Michael Smith Building, Oxford Road, Manchester, M13 9PT, UK.
Christophe BiotUniv. Lille, CNRS, UMR 8576 - UGSF - Unité de Glycobiologie Structurale et Fonctionnelle, F-59000, Lille, France.ORCID http://orcid.org/0000-0002-7396-1959
Yann GuerardelUniv. Lille, CNRS, UMR 8576 - UGSF - Unité de Glycobiologie Structurale et Fonctionnelle, F-59000, Lille, France.ORCID http://orcid.org/0000-0003-4967-9512
Willy MorelleUniv. Lille, CNRS, UMR 8576 - UGSF - Unité de Glycobiologie Structurale et Fonctionnelle, F-59000, Lille, France.
Daniel UngarDepartment of Biology, University of York, York, YO10 5DD, UK.ORCID http://orcid.org/0000-0002-9852-6160
Felix T WielandHeidelberg University Biochemistry Center, Heidelberg University, Heidelberg, 69120, Germany.
Eija JokitaloCell and Molecular Biology Program, Institute of Biotechnology, University of Helsinki, Helsinki, 00014, Finland.
May TassabehjiSchool of Biology, Faculty of Biology, Medicine and Health, University of Manchester, The Michael Smith Building, Oxford Road, Manchester, M13 9PT, UK.
Uwe KornakBerlin-Brandenburg Centre for Regenerative Therapies (BCRT), Institut fuer Medizinische Genetik und Humangenetik, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, 13353, Germany.
Martin LoweSchool of Biology, Faculty of Biology, Medicine and Health, University of Manchester, The Michael Smith Building, Oxford Road, Manchester, M13 9PT, UK. martin.lowe@manchester.ac.uk.
University of Manchester · GBCentre National de la Recherche Scientifique · FRUniversity of York · GBHeidelberg University · DEHumboldt-Universität zu Berlin · DEUniversity of Helsinki · FIManchester Academic Health Science Centre · GB

Funding

Medical Research Council MR/N000366/1Wellcome Trust
6 · The paper itself

Abstract

COPI is a key mediator of protein trafficking within the secretory pathway. COPI is recruited to the membrane primarily through binding to Arf GTPases, upon which it undergoes assembly to form coated transport intermediates responsible for trafficking numerous proteins, including Golgi-resident enzymes. Here, we identify GORAB, the protein mutated in the skin and bone disorder gerodermia osteodysplastica, as a component of the COPI machinery. GORAB forms stable domains at the trans-Golgi that, via interactions with the COPI-binding protein Scyl1, promote COPI recruitment to these domains. Pathogenic GORAB mutations perturb Scyl1 binding or GORAB assembly into domains, indicating the importance of these interactions. Loss of GORAB causes impairment of COPI-mediated retrieval of trans-Golgi enzymes, resulting in a deficit in glycosylation of secretory cargo proteins. Our results therefore identify GORAB as a COPI scaffolding factor, and support the view that defective protein glycosylation is a major disease mechanism in gerodermia osteodysplastica.

Indexed as

Adaptor Proteins, Vesicular TransportBone DiseasesCarrier ProteinsCells, CulturedCoat Protein Complex IDNA-Binding ProteinsDwarfismEnzymesGlycosylationGolgi ApparatusGolgi Matrix ProteinsHEK293 CellsHeLa CellsHumansMutationProtein BindingAdaptor Proteins, Vesicular TransportCarrier ProteinsCoat Protein Complex IDNA-Binding ProteinsEnzymesGolgi Matrix ProteinsGORAB protein, humanSCYL1 protein, humanTranscription Factors

Identifiers

PMID30631079
PMCPMC6328613
OpenAlexW2909597559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.